<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ContentLora: Gene editing and gene therapy</title><description>New and updated Gene editing and gene therapy pages on ContentLora.</description><link>https://contentlora.com/</link><language>en</language><atom:link href="https://contentlora.com/topics/gene-editing/feed.xml" rel="self" type="application/rss+xml"/><item><title>Base editing</title><link>https://contentlora.com/wiki/base-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/base-editing/</guid><description>Base editing rewrites a single DNA letter without cutting both strands. How it works, the first patients treated, and pivotal trials in 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>Casgevy (exa-cel)</title><link>https://contentlora.com/wiki/casgevy/</link><guid isPermaLink="true">https://contentlora.com/wiki/casgevy/</guid><description>Casgevy is the first approved CRISPR medicine, an edited stem cell therapy for sickle cell disease and beta-thalassemia. Approvals, data and status.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>CRISPR-Cas9</title><link>https://contentlora.com/wiki/crispr-cas9/</link><guid isPermaLink="true">https://contentlora.com/wiki/crispr-cas9/</guid><description>CRISPR-Cas9 is the RNA-guided DNA-cutting tool behind modern gene editing and the first approved CRISPR medicine. Origins, uses and limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>CRISPR Therapeutics</title><link>https://contentlora.com/wiki/crispr-therapeutics/</link><guid isPermaLink="true">https://contentlora.com/wiki/crispr-therapeutics/</guid><description>CRISPR Therapeutics is the Swiss-based gene-editing company behind Casgevy with Vertex, now running in vivo CRISPR trials in heart and liver disease.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Intellia Therapeutics</title><link>https://contentlora.com/wiki/intellia-therapeutics/</link><guid isPermaLink="true">https://contentlora.com/wiki/intellia-therapeutics/</guid><description>Intellia Therapeutics develops in vivo CRISPR therapies. Lonvo-z for hereditary angioedema is under FDA review; nex-z trials resumed after a 2025 hold.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Lipid nanoparticle delivery for gene editing</title><link>https://contentlora.com/wiki/lipid-nanoparticle-delivery/</link><guid isPermaLink="true">https://contentlora.com/wiki/lipid-nanoparticle-delivery/</guid><description>Lipid nanoparticles carry CRISPR and base-editor instructions into the liver. How they work in gene editing, key trials and their limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>Personalized (bespoke) gene editing</title><link>https://contentlora.com/wiki/personalized-gene-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/personalized-gene-editing/</guid><description>Personalized gene editing builds an editor for one patient&apos;s mutation. The 2025 CPS1 case, how it was made and how the FDA plans to regulate it.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Prime editing</title><link>https://contentlora.com/wiki/prime-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/prime-editing/</guid><description>Prime editing is a &quot;search-and-replace&quot; gene-editing method. How it works, the first human data in 2025, and the road to a first filing.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>Gene editing tracker: approvals, trials and setbacks</title><link>https://contentlora.com/events/gene-editing-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/gene-editing-tracker/</guid><description>A dated, sourced timeline of gene-editing milestones: Casgevy approvals, in vivo CRISPR trials, base and prime editing, FDA actions and safety events.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Who can get gene-editing cures? The access and cost debate</title><link>https://contentlora.com/analysis/gene-therapy-access-debate/</link><guid isPermaLink="true">https://contentlora.com/analysis/gene-therapy-access-debate/</guid><description>Gene-editing therapies like Casgevy can cost millions and need specialist centres. The evidence on access, payment models and global reach in 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Analysis</category><category>gene-editing</category><category>health</category><category>policy</category></item><item><title>How safe is in vivo gene editing? The 2026 debate</title><link>https://contentlora.com/analysis/in-vivo-editing-safety-debate/</link><guid isPermaLink="true">https://contentlora.com/analysis/in-vivo-editing-safety-debate/</guid><description>In vivo CRISPR therapies are nearing approval, but a 2025 trial death and AAV liver deaths raised safety questions. What the evidence shows.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Analysis</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Gene editing in 2026: a crash course</title><link>https://contentlora.com/explain/gene-editing/</link><guid isPermaLink="true">https://contentlora.com/explain/gene-editing/</guid><description>A sourced crash course on CRISPR, base and prime editing, delivery, approved therapies like Casgevy and where gene editing stands in October 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>How CRISPR gene editing works: cutting, base and prime editing</title><link>https://contentlora.com/explain/how-crispr-works/</link><guid isPermaLink="true">https://contentlora.com/explain/how-crispr-works/</guid><description>How CRISPR-Cas9 finds and cuts DNA, how base and prime editors change DNA without double-strand breaks, and why the difference matters for safety.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>How gene therapies are delivered: ex vivo, viral vectors and LNPs</title><link>https://contentlora.com/explain/how-gene-therapy-delivery-works/</link><guid isPermaLink="true">https://contentlora.com/explain/how-gene-therapy-delivery-works/</guid><description>How gene editors and gene therapies reach cells: editing cells outside the body, viral vectors like AAV and lentivirus, and lipid nanoparticles.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item></channel></rss>